These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28061828)

  • 21. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
    Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
    J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
    Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between lifestyle, gender and risk for developing end-stage renal failure in IgA nephropathy: a case-control study within 10 years.
    Huang PP; Shu DH; Su Z; Luo SN; Xu FF; Lin F
    Ren Fail; 2019 Nov; 41(1):914-920. PubMed ID: 31580172
    [No Abstract]   [Full Text] [Related]  

  • 26. 30-year follow-up study of IgA nephritis in a Southeast Asian population: an evaluation of the Oxford histological classification
.
    Woo KT; Lim CC; Foo MW; Loh HL; Jin AZ; Chin YM; Choo JC; Tan PH; Chow KY; Choong LH; Tan HK; Wong KS; Chan CM
    Clin Nephrol; 2016 Nov; 86 (2016)(11):270-278. PubMed ID: 27641054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
    Liu Y; Zhang Y; Liu D; Tan X; Tang X; Zhang F; Xia M; Chen G; He L; Zhou L; Zhu X; Liu H
    Kidney Blood Press Res; 2018; 43(6):1852-1864. PubMed ID: 30537719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study.
    Yuan Y; Wang Q; Ni Z; Che X; Cao L; Shao X; Zhang M; Xie Y; Qi C; Zhou W; Tian L; Mou S
    J Transl Med; 2015 Jun; 13():186. PubMed ID: 26048044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
    Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
    Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of IgA nephropathy in advanced-age patients.
    Oshima Y; Moriyama T; Itabashi M; Takei T; Nitta K
    Int Urol Nephrol; 2015 Jan; 47(1):137-45. PubMed ID: 25388352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of time-averaged serum uric acid level with clinicopathological information and long-term outcomes in patients with IgA nephropathy.
    Weng M; Fu B; Zhuo Y; Lin J; Zou Z; Chen Y; Cui J; Li G; Chen C; Xu Y; Jiang D; Wan J
    PeerJ; 2024; 12():e17266. PubMed ID: 38650643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Nagata M; Tsuchimoto A; Hirakata H; Kitazono T; Tsuruya K
    Clin Exp Nephrol; 2016 Oct; 20(5):689-698. PubMed ID: 26564155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.
    Pan M; Zhou Q; Zheng S; You X; Li D; Zhang J; Chen C; Xu F; Li Z; Zhou Z; Zhang J
    Immunol Res; 2018 Jun; 66(3):381-391. PubMed ID: 29850970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission.
    Ni Z; Yuan Y; Wang Q; Cao L; Che X; Zhang M; Xie Y; Qi C; Mou S
    J Transl Med; 2014 Jul; 12():194. PubMed ID: 25011573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
    Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological Features to Predict Progression of IgA Nephropathy with Mild Proteinuria.
    Chen D; Liu J; Duan S; Chen P; Tang L; Zhang L; Feng Z; Cai G; Wu J; Chen X
    Kidney Blood Press Res; 2018; 43(2):318-328. PubMed ID: 29529608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    Mohd R; Mohammad Kazmin NE; Abdul Cader R; Abd Shukor N; Wong YP; Shah SA; Alfian N
    PLoS One; 2021; 16(4):e0249592. PubMed ID: 33831052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.